PMID- 22493147 OWN - NLM STAT- MEDLINE DCOM- 20120601 LR - 20191210 IS - 0237-7896 (Print) IS - 0237-7896 (Linking) VI - 27 IP - 1 DP - 2012 TI - [The phenomenon of drug change in the interviews with injecting drug users]. PG - 29-47 AB - INTRODUCTION: Important part of the studies on drug use deals with drug use transitions because of their public health consequences. Narrating of drug use change states the active decision making in the centre of the process with adding mental states of the participants to the change process. The transitional narratives can be embedded in the social context of "risk environment". METHODS: In the micro-segregation of the Middle-Jozsefvaros (8th district, Budapest) the Blue Point Foundation runs a needle-exchange service in its "Contact Programme". Here the number of registered clients was 2066 in 2010. The study participants were recruited from the clients of this needle-exchange service (from December 2010 to February 2011). The criterion of entering the study sample was injecting mephedrone in the past 30 days. 17 participants were interviewed. The life story interviews had been coded thematically; it had been done until new codes did not carry new meanings. RESULTS: Study participants speak about rapid tolerance and more intensive use of mephedrone after changing their usual drug. This use is more risky because of more frequent injecting. The effect of mephedrone was described like 3,4- Methylenedioxymethamphetamine (MDMA) and cocaine. In the interviews the usual pattern was narrating the positive effects of mephedrone and after this text the narrating of the negative effects. The "risk narrative" and the "enjoyment narrative" were presented separately in the interviews. CONCLUSIONS: Not the expansion of the drug market, but the drug change was observed: earlier drugs to mephedrone or parallel use of mephedrone with earlier drugs (amphetamine and heroin). The purity and availability of heroin and the increase availability of mephedrone may take a role in this process. The absent of drug market expansion was explained by the closeness of the micro-segregation. Results raise attention of the public health consequences of drug change and the proper training of professionals for this change. FAU - Racz, Jozsef AU - Racz J AD - ELTE Pedagogiai es Pszichologiai Kar, Pszichologiai Intezet, Budapest, Hungary. racz.jozsef@ppk.elte.hu FAU - Csak, Robert AU - Csak R FAU - Farago, Renata AU - Farago R FAU - Vadasz, Viktoria AU - Vadasz V LA - hun PT - Journal Article TT - A drogvaltas jelensege injekcios droghasznalokkal keszult interjukban. PL - Hungary TA - Psychiatr Hung JT - Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata JID - 9426825 RN - 0 (Designer Drugs) RN - 0 (Dopamine Uptake Inhibitors) RN - 0 (Illicit Drugs) RN - 0 (Narcotics) RN - 44RAL3456C (Methamphetamine) RN - 70D95007SX (Heroin) RN - 8BA8T27317 (mephedrone) RN - CK833KGX7E (Amphetamine) RN - I5Y540LHVR (Cocaine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adolescent MH - Adult MH - Amphetamine/administration & dosage MH - Cocaine/administration & dosage MH - Cocaine-Related Disorders/psychology MH - Designer Drugs/*administration & dosage/adverse effects MH - Dopamine Uptake Inhibitors/administration & dosage MH - Drug Users/*psychology MH - Female MH - Heroin/administration & dosage MH - Humans MH - Hungary/epidemiology MH - *Illicit Drugs/adverse effects MH - Interview, Psychological MH - Male MH - Methamphetamine/administration & dosage/adverse effects/*analogs & derivatives MH - Middle Aged MH - N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage MH - Narcotics/administration & dosage MH - Narration MH - *Needle-Exchange Programs MH - Risk-Taking MH - Substance Abuse, Intravenous/epidemiology/*psychology MH - Young Adult EDAT- 2012/04/12 06:00 MHDA- 2012/06/02 06:00 CRDT- 2012/04/12 06:00 PHST- 2012/04/12 06:00 [entrez] PHST- 2012/04/12 06:00 [pubmed] PHST- 2012/06/02 06:00 [medline] PST - ppublish SO - Psychiatr Hung. 2012;27(1):29-47.